P-032 A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC)

Samankaltaisia teoksia

• Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
  Tekijä: Bahl, Ankur, et al.
  Julkaistu: (2020)
• The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
  Tekijä: Magdalena Krakowska, et al.
  Julkaistu: (2018-09-01)
• The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
  Tekijä: Krakowska, Magdalena, et al.
  Julkaistu: (2018)
• Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
  Tekijä: Rossi, Luigi, et al.
  Julkaistu: (2013)
• Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?
  Tekijä: Saif MW
  Julkaistu: (2013-06-01)